Use of Bayesian adaptive design for the multi-drug, genetic-marker-directed, non-comparative, multi-centre, multi-arm phase II National Lung Matrix Trial
- Billingham, L. (Invited speaker)
Activity: Academic and Industrial events › Guest lecture or Invited talk